Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates

- $186-188 million in total revenue and $178-180 million net product sales expected for 2023, preliminary and unaudited


- LIVMARLI net products sales of $141-143 million expected for 2023,...

Related Keywords

Canada ,Chris Peetz ,Nasdaq ,Mirum Pharmaceuticals Inc ,European Commission ,Drug Administration ,Instagram ,Linkedin ,Twitter ,Mirum Pharmaceuticals ,Eric Bjerkholt ,Chief Financial Officer ,Prescription Drug User Free Act ,Drug Application ,Healthcare Conference ,San Francisco ,Breakthrough Therapy ,Fat Soluble Vitamin ,Prescribing Informationfor ,Important Safety ,Markets ,